TrialInternational journal of colorectal disease2012

The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial.

Torben Frøstrup Hansen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.